Antibody highly specific for diffuse systemic sclerosis (scleroderma).
Overlap Syndromes (Polymyositis/Scleroderma)
A polymyositis/scleroderma overlap syndrome, sometimes called scleromyositis, is an autoimmune condition with features of two diseases at once: muscle inflammation (myositis) and scleroderma (systemic sclerosis). People may have weak muscles in the shoulders and hips, Raynaud's phenomenon, thickened skin on the fingers, joint pain and, in some cases, scarring of the lungs.
Lab tests linked to polymyositis/scleroderma overlap:
- Anti-Scl-70 antibodies: typical of systemic sclerosis. They are seen in some people with overlap features.
- Doctors also order ANA, a myositis antibody panel (including anti-PM-Scl and anti-Ku, which are most closely linked to this overlap), creatine kinase (CK) and aldolase. Lung function tests and a lung CT check for lung involvement.
How results are read:
- A raised CK shows active muscle damage. It is also used to follow how the muscle inflammation responds to treatment.
- The specific antibody helps define the overlap and predict risks, especially lung disease.
- A positive antibody without symptoms doesn't diagnose an overlap syndrome. The diagnosis rests on muscle, skin and organ findings, sometimes with a muscle biopsy or MRI.
When to see a doctor:
- Get urgent care for difficulty swallowing, choking on food or drink, or new breathlessness.
- Get urgent care for a sudden rise in blood pressure, severe headache or less urine, which can signal kidney involvement.
Clinical takeaway: polymyositis/scleroderma overlap is diagnosed from clinical findings and supporting tests. Myositis-associated antibodies such as anti-PM-Scl and anti-Ku can support the diagnosis but don't establish it alone.
Biomarkers related to this condition
1 marker linked to this condition
Looking for a different marker? Browse all biomarkers →